NL-OMON37974已完成3 期
Effect of adding vildagliptin to start of insulin treatment in patients with type 2 diabetes - Vildagliptin and insulin in type 2 diabetes
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Type 2 diabetes
- •Failure on oral medication and start of insulin treatment with once daily long-acting insulin (glargine)
- •HbA1c 7-9%
排除标准
- •-Pregnant women or women in the fertile period of life without adequate birth-control
- •-Type I DM, or secondary form of DM (eg pancreatic injury, prednisone induced)
- •- Acute metabolic complications (severe hypoglycaemia, hospital-admission for uncontrolled hyperglycemia) during the last 6 months
- •- Severe cardiac (LVEF < 30%) or a history of or current hepatic, or renal impairment (creatinine clearance <50 ml/min)
研究者
相似试验
进行中（未招募）
不适用
Effect of adding vildagliptin to start of insulin treatment in combination with metformin in patients with type 2 diabetes - Effect of adding vildagliptin to insulin treatmentpatients with type 2 diabetes, failing on maximal oral glucose-lowering drugs, starting on insulin therapy in combination with standard metfromin (2 x 850)MedDRA version: 9.1Level: LLTClassification code 10012594Term: DiabetesEUCTR2009-010967-18-NLniversity Medical Centre Utrecht40
已完成
不适用
Effect of adding vildagliptin to start of insulin treatment in patients with type 2 diabetes.DiabetesNL-OMON29400MCUtrecht40
已完成
不适用
The effects of vildagliptin in addition to insulin on glycemic control in hemodialysis patients with type 2 diabetes mellitustype 2 diabetes mellitus undergoing hemodialysisJPRN-UMIN000010703Saiseikai Kumamoto Hospital40
招募中
不适用
Effects of Vildagliptin addition versus standard therapy on glycemic excursion in type2 diabetic patients after coronary intervention therapy: a 8-months, randomized, open-label, parallel-group comparison.Type 2 diabetes mellitusJPRN-UMIN000017619Teikyo University School of Medicine60
未知
3 期
Efficacy and safety of vildagliptin as add-on therapy to metformin in patients with type 2 diabetesType 2 diabetes mellitusJPRN-jRCT2080221679ovartis Pharma K.K.136